# US Capsule Endoscopy Market > US Capsule Endoscopy Market Research Report: Size, Share, Trend Analysis By Product (Capsule Endoscopes, Small Bowel, Esophageal, Colon, Systems), By Applications (OGIB (Obscure GI Tract Bleeding), Crohn’s Disease, Small Intestine Tumor, Others) and By End-User (Hospitals, Ambulatory Surgery Centers, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.2% - **2024:** $ 127.4 Million - **2025:** $ 139.12 Million - **2035:** $ 335.44 Million - **Key Players:** Medtronic (US), Olympus Corporation (JP), Given Imaging (IL), PENTAX Medical (JP), IntroMedic (KR), CapsoVision (US), SurgiQuest (US), Check-Cap (IL) **Report ID:** MRFR/MED/18053-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-capsule-endoscopy-market-19600 --- ## Market Summary ## **US Capsule Endoscopy Market Overview** ### **US Capsule Endoscopy Market Size and Growth** As per MRFR analysis, the US Capsule Endoscopy Market Size was estimated at 117.6 (USD Million) in 2023. The US Capsule Endoscopy Market Industry is expected to grow from 127.4 (USD Million) in 2024 to 314.1 (USD Million) by 2035. The US Capsule Endoscopy Market CAGR (growth rate) is expected to be around 8.549% during the forecast period (2025 - 2035). ### **Key US Capsule Endoscopy Market Trends Highlighted** The US Capsule Endoscopy Market is experiencing notable trends driven by advancements in technology and an increase in the prevalence of gastrointestinal disorders. One of the main market drivers is the rising demand for non-invasive diagnostic procedures, as capsule endoscopy offers a less intrusive alternative to traditional endoscopic methods. This shift is encouraged by both healthcare providers and patients seeking safer options, particularly for conditions like Crohn's disease and gastrointestinal bleeding. Opportunities are emerging for innovative capsule designs and improved imaging capabilities, as manufacturers focus on enhancing the diagnostic accuracy and comfort of these devices. The growth of telemedicine in the US further supports these advancements, enabling better access to care and remote monitoring of patients using capsule endoscopy. Additionally, regulatory support from the FDA has facilitated quicker approvals for new capsule technologies, inviting more players to enter the market. In recent times, an increasing emphasis on personalized healthcare in the US has also impacted the capsule endoscopy market. Healthcare providers are increasingly recommending this diagnostic tool because it can provide individualized insights into a patient's gastrointestinal health. Improvements in data analytics and integration with electronic health records are enhancing the value of capsule endoscopy, allowing for better patient management. Furthermore, awareness campaigns about gastrointestinal diseases are helping to drive demand as more patients become informed and seek early diagnosis and treatment options. Overall, these trends indicate a promising future for the capsule endoscopy sector within the US healthcare landscape. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Capsule Endoscopy Market Drivers** ### **Rising Incidence of Gastrointestinal Disorders** The growing prevalence of gastrointestinal disorders such as Crohn's disease, ulcerative colitis, and gastrointestinal bleeding significantly drives the US [Capsule Endoscopy Market](../../../reports/capsule-endoscopy-market-1359) Industry. According to the Centers for Disease Control and Prevention (CDC), gastrointestinal disorders affect millions of Americans, with conditions like Crohn's disease impacting approximately 780,000 individuals in the United States alone. The rise in these cases necessitates advanced diagnostic techniques like capsule endoscopy, which provides a non-invasive solution. With the National Institute of Diabetes and Digestive and Kidney Diseases recommending capsule endoscopy as an effective diagnostic procedure for small bowel conditions, the demand for this technology is expected to increase, impacting market growth positively. The ongoing focus of healthcare providers to improve diagnostic capabilities and ensure timely interventions further solidifies the role of capsule endoscopy in managing gastrointestinal issues effectively. ### **Technological Advancements in Capsule Endoscopy** Technological innovations in capsule endoscopy systems contribute significantly to the growth of the US Capsule Endoscopy Market Industry. The development of high-definition imaging technology, improved battery life, and real-time data transmission features have made these devices more efficient. For instance, advancements in capsule design allow for enhanced visualization of gastrointestinal tract areas previously difficult to assess. Research from the Food and Drug Administration (FDA) indicates that the approval of several high-tech capsule endoscopes in recent years demonstrates the commitment to cutting-edge solutions. As more healthcare institutions adopt these advanced technologies, the demand for capsule endoscopes will likely increase in the coming years. ### **Growing Public Awareness and Acceptance** Increased awareness and acceptance of capsule endoscopy as a viable diagnostic tool are essential drivers of the US Capsule Endoscopy Market Industry. Educational campaigns by organizations like the American Gastroenterological Association have made significant impacts, informing both healthcare professionals and patients about the benefits and effectiveness of capsule endoscopy. A survey conducted by patient advocacy groups indicates that over 60% of individuals diagnosed with gastrointestinal disorders are open to discussing and trying new diagnostic procedures, including capsule endoscopy. This growing willingness among patients to pursue cutting-edge diagnostic techniques boosts market growth as more individuals seek out effective and non-invasive options for gastrointestinal testing. ### **Rise in Healthcare Expenditures and Insurance Coverage** The increase in healthcare expenditures and insurance coverage for advanced diagnostic procedures propels the US Capsule Endoscopy Market Industry forward. According to the American Hospital Association, U.S. health care spending rose by approximately 9.7% in a recent year, reflecting a growing investment in medical technologies, including capsule endoscopy. Furthermore, insurance providers are expanding their coverage for capsule endoscopy procedures, recognizing their diagnostic importance and efficiency. The Centers for Medicare and Medicaid Services have been actively working to improve access to these innovative diagnostic tools, thereby encouraging more patients to opt for capsule endoscopy. As a result, the synergy of rising healthcare costs and better insurance coverage translates to increased market growth prospects. ## **US Capsule Endoscopy Market Segment Insights** ### **Capsule Endoscopy Market Product Insights** The US Capsule Endoscopy Market is witnessing substantial growth, driven by advancements in technology and increasing awareness of gastrointestinal disorders. The Product segment of the market is crucial, encompassing various devices pivotal to the diagnostic process. Capsule endoscopes are at the forefront, providing a non-invasive method for visualizing the small intestine and other areas that traditional endoscopy may not reach, which enhances patient comfort and diagnosis accuracy. Within this segment, the small bowel focus is particularly significant, as conditions such as Crohn's disease and small bowel bleeding are increasingly prevalent among the population, contributing to a higher demand for innovative diagnostic solutions. The esophageal segment, addressing disorders like esophageal varices and strictures, has gained traction due to the rise in cases linked to lifestyle diseases, thus creating opportunities for expansive product development. Moreover, the colon segment plays a critical role in cancer detection, given the rising incidence of colorectal cancer in the US, which underscores the necessity for effective screening technologies. Systems that integrate these devices with advanced imaging and data analysis capabilities are also emerging, enhancing workflow efficiency in healthcare settings. The growing emphasis on early detection and non-invasive procedures is driving the growth of these products, making them vital components of the overall healthcare landscape. Key trends, such as the integration of artificial intelligence in reading endoscopic data and the development of more sophisticated capsule designs capable of capturing higher resolution images, further indicate a transformative phase within the US Capsule Endoscopy Market. Collectively, these factors shape a dynamic ecosystem for the Product segment, presenting ample opportunities for innovation and growth in the years to come. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Capsule Endoscopy Market Application Insights** The US Capsule Endoscopy Market has experienced substantial growth in its Application segment, driven by an increasing prevalence of gastrointestinal disorders. Among the various conditions addressed by capsule endoscopy, OGIB (Obscure GI Tract Bleeding) is particularly significant, as it often presents diagnostic challenges and requires non-invasive solutions for effective management. Crohn's Disease, a chronic inflammatory bowel condition, continues to gain attention due to rising incidence rates in the United States, emphasizing the need for advanced diagnostic tools like capsule endoscopy. The segment catering to Small Intestine Tumors is also crucial, given the complexities of early tumor detection in this area. It reflects the ongoing advancements in medical technology to improve diagnostic accuracy and patient outcomes. Additionally, other applications within this market segment are expanding as healthcare providers seek innovative and minimally invasive solutions for various gastrointestinal disorders. These trends underscore the importance of capsule endoscopy as an essential diagnostic tool in the US healthcare landscape, aligning with broader efforts to enhance patient care and optimize treatment pathways. ### **Capsule Endoscopy Market End-User Insights** The End-User segment of the US Capsule Endoscopy Market is fundamentally shaped by the diverse settings in which capsule endoscopy procedures are conducted. Hospitals hold a significant share as they offer advanced diagnostic facilities and comprehensive care, which is essential for effective patient management. Ambulatory Surgery Centers are increasingly popular due to their ability to provide outpatient care, making the procedure more accessible for patients while reducing hospital-related expenses. The category of Others includes various healthcare settings, such as clinics and specialty facilities, which also contribute to the overall market by catering to specific patient needs. The upward trend towards minimally invasive procedures and growing consumer awareness regarding gastrointestinal disorders are key drivers enhancing the adoption of capsule endoscopy across these end-users. Additionally, the increasing investment in healthcare infrastructure within the US facilitates the growth of this market segment, with hospitals and surgery centers focused on upgrading their technological capabilities. The US Capsule Endoscopy Market statistics indicate a promising outlook, with relevance to various healthcare frameworks and patient care strategies. ## **US Capsule Endoscopy Market Key Players and Competitive Insights** The US Capsule Endoscopy Market is witnessing a dynamic competitive landscape characterized by rapid technological advancements and an increasing prevalence of gastrointestinal disorders. The market's growth is fueled by the rising need for non-invasive diagnostic procedures and the growing adoption of advanced medical technologies among healthcare providers. Competitive insights reveal that companies within this space are focusing on developing innovative products that enhance diagnostic accuracy and patient comfort while reducing procedural time. Additionally, collaboration with healthcare facilities and expanding distribution networks are central strategies employed by key market players to strengthen their market position. As the demand for capsule endoscopy continues to rise, the competitive arena is expected to become increasingly active, with companies striving to gain a competitive edge through differentiation and superior service offerings. CapsoVision has established itself as a significant player in the US Capsule Endoscopy Market by providing unique and effective solutions for gastrointestinal diagnosis. The company is known for its innovative technology, which includes a cap-like device that offers a different approach to capsule endoscopy by freeing the patient from the complexities associated with traditional methods. This distinct technology underscores CapsoVision's commitment to improving patient experience and diagnostic capabilities. Continuing to focus on research and development, CapsoVision invests in innovation to enhance its product line further and increase its therapeutic applications. With a growing market presence, CapsoVision stands out due to its strong emphasis on user-friendly systems and commitment to improving the standards of care in gastrointestinal diagnostics. Wolf Medical Supply has made significant strides in the US Capsule Endoscopy Market by emphasizing quality and reliability in its products and services. The company operates as a distributor and supplier of various medical devices, including technology specifically designed for capsule endoscopy procedures. The strengths of Wolf Medical Supply lie in its extensive market presence and strong relationships with healthcare providers, which enable the company to meet the evolving needs of the market effectively. The company offers a range of key products, enhancing the reliability of the diagnostic process while ensuring comprehensive support for healthcare facilities. Wolf Medical Supply has also pursued strategic mergers and acquisitions to broaden its portfolio and enhance its competitive position within the US market. Its focus on delivering high-quality solutions and expanding its product offerings continues to reinforce its role in the ever-evolving arena of capsule endoscopy. ### **Key Companies in the US Capsule Endoscopy Market Include** ## **US Capsule Endoscopy Market Industry Developments** The US Capsule Endoscopy Market has seen notable developments recently, with CapsoVision, Medtronic, and Olympus Corporation leading advancements in technology and product offerings. In October 2023, Medtronic announced enhancements to its capsule system, improving diagnostic accuracy for gastrointestinal disorders. Additionally, in August 2023, Boston Scientific reported an expansion in its capsule offerings, targeting increased accessibility in healthcare facilities across the US. In terms of mergers and acquisitions, Credo Medical acquired Given Imaging in September 2023, a move set to enhance their product portfolio and market presence, supported by multiple trusted news sources. The market valuation for companies such as PillCam and SRS Medical has increased significantly, largely attributed to rising demand for minimally invasive diagnostic tools in the US healthcare system, which promotes faster recovery for patients. Over the past two to three years, the focus on technological improvements in capsule endoscopy has attracted investments, positioning this sector as a rapidly growing area within the healthcare market, driven by an increasing prevalence of gastrointestinal diseases nationwide. Overall, these factors signal a dynamic and evolving landscape within the US Capsule Endoscopy Market. ## **US Capsule Endoscopy Market Segmentation Insights** ### **Capsule Endoscopy Market Product Outlook** ### **Capsule Endoscopy Market Application Outlook** ### **Capsule Endoscopy Market End-User Outlook** ## Market Drivers ### Rising Healthcare Expenditure in the US The increase in healthcare expenditure in the US is positively impacting the capsule endoscopy market. As healthcare budgets expand, there is a greater allocation of funds towards advanced diagnostic technologies. The US healthcare system is projected to reach approximately $4.3 trillion by 2025, with a significant portion dedicated to innovative medical devices. This financial commitment allows for the adoption of cutting-edge technologies, including capsule endoscopy, which offers efficient and effective diagnostic solutions. Additionally, as insurance coverage for these procedures improves, more patients are likely to seek capsule endoscopy as a viable option for gastrointestinal evaluation. The financial support for advanced medical technologies is expected to drive growth in the capsule endoscopy market, making it more accessible to a broader patient population. ### Technological Innovations in Capsule Design Technological advancements in capsule design are significantly influencing the capsule endoscopy market. Innovations such as improved imaging capabilities, enhanced battery life, and real-time data transmission are making these devices more effective and user-friendly. For instance, the introduction of high-definition cameras and advanced wireless technology allows for clearer images and faster data processing. These enhancements not only improve diagnostic accuracy but also increase patient comfort and compliance. As manufacturers continue to invest in research and development, the market is likely to see a surge in new products that cater to diverse clinical needs. The integration of artificial intelligence in image analysis may further streamline the diagnostic process, making capsule endoscopy an increasingly attractive option for healthcare providers. ### Regulatory Support for Innovative Medical Devices Regulatory support for innovative medical devices is a vital driver for the capsule endoscopy market. The US Food and Drug Administration (FDA) has established streamlined pathways for the approval of new medical technologies, encouraging manufacturers to develop and introduce advanced capsule endoscopy systems. This regulatory environment fosters innovation and ensures that patients have access to the latest diagnostic tools. the FDA's commitment to promoting safe and effective medical devices is likely to enhance growth potential. Furthermore, as regulatory bodies continue to recognize the importance of non-invasive diagnostic methods, the approval process for capsule endoscopy devices may become even more efficient. This supportive framework is expected to attract investment in the capsule endoscopy market, leading to the development of next-generation products that meet evolving clinical needs. ### Increasing Prevalence of Gastrointestinal Disorders The rising incidence of gastrointestinal disorders in the US is a primary driver for the capsule endoscopy market. Conditions such as Crohn's disease, ulcerative colitis, and gastrointestinal bleeding are becoming more common, necessitating advanced diagnostic tools. According to recent data, approximately 1.6 million Americans suffer from inflammatory bowel diseases, which often require thorough examination of the small intestine. Capsule endoscopy offers a non-invasive solution, allowing for detailed visualization of the gastrointestinal tract. This method is particularly beneficial for patients who may not tolerate traditional endoscopic procedures. As awareness of these disorders increases, healthcare providers are likely to adopt capsule endoscopy more widely, thereby expanding the market. The growing patient population seeking effective diagnostic options is expected to propel the capsule endoscopy market forward in the coming years. ### Growing Awareness and Acceptance Among Healthcare Professionals The growing awareness and acceptance of capsule endoscopy among healthcare professionals is a crucial driver for the market. As more physicians recognize the benefits of this non-invasive diagnostic tool, its adoption is likely to increase. Educational initiatives and training programs are being implemented to familiarize healthcare providers with the technology and its applications. This shift in perception is supported by clinical studies demonstrating the efficacy of capsule endoscopy in diagnosing small bowel disorders. Furthermore, as healthcare systems emphasize patient-centered care, the demand for less invasive procedures is expected to rise. This trend may lead to an increase in referrals for capsule endoscopy, thereby boosting the market. The collaboration between manufacturers and medical institutions to promote the technology is also anticipated to enhance its visibility and acceptance. ## Future Outlook The [Capsule Endoscopy Market](https://www.marketresearchfuture.com/reports/capsule-endoscopy-market-1359) is projected to grow at a 9.2% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of gastrointestinal disorders, and rising demand for non-invasive procedures. **New opportunities:** - Development of AI-driven analytics for enhanced diagnostic accuracy. Expansion of telemedicine platforms integrating capsule endoscopy services. Partnerships with healthcare providers for bundled service offerings. By 2035, the capsule endoscopy market is expected to achieve substantial growth, driven by innovation and strategic partnerships. ## Segment Insights ### By Product: Capsule Endoscopes (Largest) vs. Systems (Fastest-Growing) In the US capsule endoscopy market, Capsule Endoscopes hold the largest share, dominating the segment with their advanced imaging technology and non-invasive approach. Systems, while currently smaller in market share, are rapidly gaining traction due to their innovative features and enhanced functionality, appealing to a growing number of healthcare providers. The growth trends in this segment are driven by increasing awareness of gastrointestinal diseases and the rising demand for minimally invasive diagnostic options. Technological advancements, coupled with a rising geriatric population prone to digestive disorders, are propelling the adoption of both Capsule Endoscopes and Systems. As healthcare providers seek to improve patient outcomes, the focus on these products is expected to heighten in the coming years. Capsule Endoscopes (Dominant) vs. Systems (Emerging) Capsule Endoscopes are at the forefront of the segment, characterized by their ability to provide high-quality images of the gastrointestinal tract with minimal discomfort for patients. Their non-invasive nature makes them the preferred choice among physicians and patients alike. On the other hand, Systems are emerging as a significant contender, focusing on integrated solutions that increase diagnostic efficiency and reliability. The ongoing enhancements in System capabilities, including real-time data transmission and improved battery life, position them well for future growth. As healthcare settings continue to embrace technological innovation, both Capsule Endoscopes and Systems will play crucial roles in shaping the landscape of gastrointestinal diagnostics. ### By Application: OGIB (Largest) vs. Crohn’s Disease (Fastest-Growing) In the US capsule endoscopy market, the application segment is primarily dominated by OGIB, which accounts for the largest share of the overall market. This segment's prevalence is driven by the increasing incidence of obscure gastrointestinal bleeding cases, which leads to a higher demand for effective diagnostic solutions. Crohn’s Disease follows as a significant application area, representing a substantial portion of the market, bolstered by advancements in treatment protocols and growing awareness of gastrointestinal disorders. As the market evolves, Crohn’s Disease emerges as the fastest-growing segment, reflecting improved healthcare access and enhanced diagnostic technology. The rise in juvenile cases and the effectiveness of capsule endoscopy in monitoring disease progression are key drivers. Furthermore, increasing investments in gastrointestinal therapeutics encourage innovation and expand the capabilities of capsule endoscopy, positioning it favorably within the US capsule endoscopy market. Application: OGIB (Dominant) vs. Crohn’s Disease (Emerging) OGIB holds a dominant position in the application segment of the US capsule endoscopy market, making it a critical focus for manufacturers and healthcare providers. This application benefits from a well-established market presence due to its high incidence rates and the urgent need for accurate diagnostic methods. In contrast, Crohn's Disease, while currently an emerging segment, is rapidly gaining traction as awareness and diagnosis improve. The growth in this area is partly attributed to a rise in the number of patients diagnosed, alongside the increasing utilization of capsule endoscopy for ongoing disease management. This dual focus on OGIB and Crohn's Disease illustrates the dynamic nature of the market, with each application contributing uniquely to the overall growth and healthcare advancements in gastrointestinal diagnostics. ### By End-User: Hospitals (Largest) vs. Ambulatory Surgery Centers (Fastest-Growing) In the US capsule endoscopy market, hospitals currently dominate the end-user segment, holding a significant market share due to their vast resources and capacity to provide extensive patient care. Ambulatory surgery centers, while smaller, are rapidly gaining ground as they offer more efficient and cost-effective solutions for less complex procedures, attracting more patients and practitioners. Other segments, including independent practices and specialized clinics, also contribute to the market but remain comparatively smaller in share. Growth trends in this segment indicate a shift towards outpatient services, driven by advancements in technology and increasing patient demand for minimally invasive procedures. Hospitals and ambulatory surgery centers are leveraging innovative capsule endoscopy technologies to enhance diagnostic accuracy and patient experience. This paradigm shift reflects a broader trend in healthcare that favors rapid diagnostic solutions and the expansion of telemedicine, further fueling the growth of outpatient care in the US capsule endoscopy market. Hospitals (Dominant) vs. Ambulatory Surgery Centers (Emerging) Hospitals play a dominant role in the US capsule endoscopy market, benefiting from their established infrastructure, specialized personnel, and ability to conduct comprehensive diagnostic procedures. These facilities are equipped to handle a wide range of patient needs, including those requiring extensive follow-up care. In contrast, ambulatory surgery centers are emerging as a preferred choice for patients seeking cost-effective, efficient, and convenient care. These centers specialize in outpatient procedures, often leading to quicker recovery times. The growth of the ambulatory surgery center segment is propelled by patient preferences for less invasive procedures and shorter wait times, indicating a shift in the healthcare landscape where convenience and efficiency are paramount. ## Competitive Benchmarking The capsule endoscopy market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for non-invasive diagnostic procedures. Key players such as Medtronic (US), Olympus Corporation (Japan), and Given Imaging (Israel) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on innovation and product development, particularly in enhancing imaging quality and patient comfort. Meanwhile, Olympus Corporation (Japan) emphasizes strategic partnerships to expand its product offerings and market reach, while Given Imaging (Israel) leverages its established reputation in gastrointestinal diagnostics to introduce cutting-edge solutions that cater to evolving patient needs.The business tactics employed by these companies reflect a moderately fragmented market structure, where localized manufacturing and supply chain optimization are pivotal. This fragmentation allows for a diverse range of products and services, catering to various segments of the healthcare market. The collective influence of these key players shapes competitive dynamics, as they strive to differentiate themselves through technological advancements and improved patient outcomes. In October Medtronic (US) announced the launch of its latest capsule endoscopy system, which integrates advanced AI algorithms to enhance diagnostic accuracy. This strategic move is significant as it positions Medtronic at the cutting edge of technology, potentially improving patient outcomes and streamlining clinical workflows. The incorporation of AI not only enhances the diagnostic capabilities but also aligns with the growing trend of digitalization in healthcare. In September Olympus Corporation (Japan) entered into a strategic partnership with a leading telehealth provider to facilitate remote monitoring of patients undergoing capsule endoscopy. This collaboration is crucial as it reflects the increasing importance of telehealth solutions in enhancing patient care and accessibility. By integrating telehealth with its capsule endoscopy offerings, Olympus aims to provide a more comprehensive service that meets the demands of modern healthcare. In August Given Imaging (Israel) expanded its product line by introducing a new capsule designed specifically for pediatric patients. This strategic expansion is noteworthy as it addresses a significant gap in the market, catering to a demographic that has unique diagnostic needs. By focusing on pediatric applications, Given Imaging not only diversifies its portfolio but also strengthens its position in the competitive landscape. As of November current trends in the capsule endoscopy market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing their competitive edge. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests a future where companies that prioritize these elements may gain a substantial advantage in the evolving market. ## Recent News & Developments The US Capsule Endoscopy Market has seen notable developments recently, with CapsoVision, Medtronic, and Olympus Corporation leading advancements in technology and product offerings. In October 2023, Medtronic announced enhancements to its capsule system, improving diagnostic accuracy for gastrointestinal disorders. Additionally, in August 2023, Boston Scientific reported an expansion in its capsule offerings, targeting increased accessibility in healthcare facilities across the US. In terms of mergers and acquisitions, Credo Medical acquired Given Imaging in September 2023, a move set to enhance their product portfolio and market presence, supported by multiple trusted news sources. The market valuation for companies such as PillCam and SRS Medical has increased significantly, largely attributed to rising demand for minimally invasive diagnostic tools in the US healthcare system, which promotes faster recovery for patients. Over the past two to three years, the focus on technological improvements in capsule endoscopy has attracted investments, positioning this sector as a rapidly growing area within the healthcare market, driven by an increasing prevalence of gastrointestinal diseases nationwide. Overall, these factors signal a dynamic and evolving landscape within the US Capsule Endoscopy Market. ## Report Scope | MARKET SIZE 2024 | 127.4(USD Million) | | --- | --- | | MARKET SIZE 2025 | 139.12(USD Million) | | MARKET SIZE 2035 | 335.44(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.2% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Olympus Corporation (JP), Given Imaging (IL), PENTAX Medical (JP), IntroMedic (KR), CapsoVision (US), SurgiQuest (US), Check-Cap (IL) | | Segments Covered | Product, Application, End-User | | Key Market Opportunities | Advancements in imaging technology enhance diagnostic capabilities in the capsule endoscopy market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the capsule endoscopy market, enhancing diagnostic capabilities. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the projected market valuation for the US capsule endoscopy market in 2035?** A: The projected market valuation for the US capsule endoscopy market in 2035 is $335.44 Million. **Q: What was the market valuation for the US capsule endoscopy market in 2024?** A: The market valuation for the US capsule endoscopy market in 2024 was $127.4 Million. **Q: What is the expected CAGR for the US capsule endoscopy market from 2025 to 2035?** A: The expected CAGR for the US capsule endoscopy market during the forecast period 2025 - 2035 is 9.2%. **Q: Which companies are considered key players in the US capsule endoscopy market?** A: Key players in the US capsule endoscopy market include Medtronic, Olympus Corporation, Given Imaging, PENTAX Medical, IntroMedic, CapsoVision, SurgiQuest, and Check-Cap. **Q: What are the main product segments in the US capsule endoscopy market?** A: The main product segments in the US capsule endoscopy market include Capsule Endoscopes, valued at $80.0 - $200.0 Million, and Systems, valued at $47.4 - $135.44 Million. **Q: What applications are driving growth in the US capsule endoscopy market?** A: Applications driving growth in the US capsule endoscopy market include OGIB, Crohn’s Disease, Small Intestine Tumor, and others, with values ranging from $25.0 to $100.0 Million. **Q: How do hospitals and ambulatory surgery centers compare as end-users in the US capsule endoscopy market?** A: In the US capsule endoscopy market, hospitals are valued at $50.96 - $132.12 Million, while ambulatory surgery centers are valued at $38.05 - $99.56 Million. **Q: What is the potential for growth in the US capsule endoscopy market?** A: The potential for growth in the US capsule endoscopy market appears robust, with a projected increase to $335.44 Million by 2035. **Q: What factors might influence the growth of the US capsule endoscopy market?** A: Factors influencing the growth of the US capsule endoscopy market may include advancements in technology, increasing prevalence of gastrointestinal disorders, and rising demand for non-invasive diagnostic procedures. **Q: What is the significance of the 2025 - 2035 forecast period for the US capsule endoscopy market?** A: The 2025 - 2035 forecast period is significant for the US capsule endoscopy market as it indicates a sustained growth trajectory, driven by an expected CAGR of 9.2%. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-capsule-endoscopy-market-19600*